Fullerton Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Fullerton Fund Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$726K	Buy	12,607 +2,538	+25%	+$146K	0.05%	50
2026 Q1	$611K	Buy	+10,069	New	+$587K	0.05%	55
2025 Q3	–	Sell	-3,547	Closed	-$164K	–	100
2025 Q2	$164K	Sell	3,547 -4,750	-57%	-$233K	0.01%	93
2025 Q1	$506K	Buy	+8,297	New	+$484K	0.03%	82
2024 Q2	–	Sell	-9,408	Closed	-$510K	–	139
2024 Q1	$510K	Buy	+9,408	New	+$479K	0.02%	71
2021 Q3	–	Sell	-3,538	Closed	-$236K	–	69
2021 Q2	$236K	Buy	+3,538	New	+$231K	0.02%	76
2020 Q4	–	Sell	-3,180	Closed	-$192K	–	81
2020 Q3	$192K	Buy	+3,180	New	+$191K	0.03%	58

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fullerton Fund Management's BMY Position: Q2 2026 in Review

Fullerton Fund Management increased its Bristol-Myers Squibb (BMY) stake by 25% in Q2 2026, buying an estimated $146K and bringing the position to 12,607 shares worth $726K. The position accounts for 0.05% of the portfolio, ranked #50.

Fullerton Fund Management first reported a position in BMY in Q3 2020 and has held it in 7 quarters since. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Fullerton Fund Management held 12,607 shares of Bristol-Myers Squibb worth $726K as of Q2 2026.
Fullerton Fund Management bought 2,538 Bristol-Myers Squibb shares in Q2 2026, an estimated $146K.
Bristol-Myers Squibb made up 0.05% of Fullerton Fund Management's portfolio in Q2 2026, its #50 holding.
Fullerton Fund Management first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 7 quarters since.
2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Fullerton Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.